Why Wall Street Is Chasing Ozempic Wannabes
Big Pharma can’t seem to get investors hyped on much beyond obesity, so many are jumping in. Most won’t win.
Big Pharma can’t seem to get investors hyped on much beyond obesity, so many are jumping in. Most won’t win.